News | January 22, 2013

Treatment Chair Developed By Procure Improves Patient Comfort, Increases Efficiency of Care

Device allows patients to sit up during cancer treatments

An innovative modification of a treatment chair used with cancer patients allows those who have problems lying down during procedures to sit upright, providing greater comfort. The modified chair was developed to be used for proton therapy but can also be used in conventional radiation therapy, providing the chair can be attached to a robotic positioner.   

Engineers at ProCure Treatment Centers, Inc. (ProCure), which develops and operates a network of proton centers in the U.S., developed an intra-cranial chair to address the difficulty some patients have when they need to lie flat for treatment. The chair also gives proton centers the option of using less expensive beam delivery systems rather than large gantry systems, the industry standard for treating these cases, as it was designed with multiple rotation points that complement the limited beam angles offered by the inclined or fixed beam systems. ProCure also developed the inclined beam technology, which can be used to treat approximately 80 percent of tumors that normally require the use of a gantry, but in a space about half the size.
“Some patients, especially those with head and neck tumors, have difficulty swallowing while lying on a standard treatment table,” said Eugen Hug, M.D., ProCure medical director and chief medical officer. “Not only is this device helpful in greatly enhancing patient comfort but it improves patient flow by allowing us to use the inclined beam system for more people.” 
The intra-cranial chair is in use at ProCure’s Oklahoma and Illinois centers and is now commercially available to other proton centers, hospitals and radiation oncology practices.
 
“Our sole focus is providing exceptional patient care and we continue to do that by developing new innovations that place our patient’s comfort front and center,” said Niek Schreuder, senior vice president of medical physics and technology at ProCure. “Our engineers at the ProCure Training and Development Center strive to bring new and improved technology to cancer therapy, not only for our center but for all practices that are treating patients who could benefit.”
 
Proton therapy is an advanced form of radiation and an important alternative to standard X-ray radiation for many patients with cancer and for some noncancerous tumors. Proton therapy has been shown to be beneficial in the treatment of a broad range of tumor types including brain, central nervous system, gastrointestinal, head and neck, lung and prostate as well as sarcomas and many pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors such as base of skull and tumors along the spinal cord.
 
For more information: www.ProCure.com
 

Related Content

MRI

Multiparametric MRI (MpMRI) has proved helpful in enhancing biopsy sampling for prostate cancer when combined with ultrasound. 

Feature | Prostate Cancer | April 10, 2017 | By Jeff Zagoudis
While prostate cancer is one of the most common cancers among American men — the third leading cause of cancer deaths...
Mevion, S250i proton therapy system, Hyperscan pencil beam scanning, installation, MedStar Georgetown University Hospital
News | Proton Therapy | April 04, 2017
April 4, 2017 — Mevion Medical Systems announced the installation of the first Mevion S250i...
proton therapy, recurrent lung cancer, clinical study, IMPT, 2017 Multidisciplinary Thoracic Cancers Symposium
News | Proton Therapy | March 24, 2017
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for...
brain FUS

Brain FUS uses an array of about 1,000 elements designed to overcome attenuation issues presented by the skull and to diffuse the heating over a large area of the brain to prevent damaging healthly tissue. 

Feature | Radiation Oncology | March 02, 2017 | By Dave Fornell
Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent...
state of the proton therapy market entering 2017, proton therapy, radiation therapy, Robust Insight survey
News | Proton Therapy | February 10, 2017
Independent market research consultancy Robust Insight recently conveyed a survey commissioned by IBA on the state of...
insightec exablate high intensity focused ultrasound system

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. Studies are underway to see if FUS can be used to treat other brain conditions and brain cancer.

Feature | Focused Ultrasound Therapy | February 03, 2017 | Dave Fornell
Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent...
oncology analytics

Mosaiq Oncology Analytics is a cloud-based solution that integrates with multiple systems, so the user can leverage the information within and beyond the oncology department.

Feature | Radiation Oncology | February 01, 2017 | By Rachael Bennett, BHS, R.T.(R)(T)
In 2016, the America Cancer Society expected 1,685,210 new cancer diagnoses in the United States alone. And according...
Mevion S250 proton therapy system, UF Health Cancer Center - Orlando Health, Airo CT scanner, Veritiy Patient Positioning System, radiation therapy
News | Proton Therapy | January 27, 2017
Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment on a...
Sponsored Content | Videos | Quality Assurance (QA) | December 20, 2016
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central...
Sponsored Content | Videos | Radiation Therapy | November 18, 2016
Accuray recently unveiled the company’s newest innovation, the Radixact Treatment Delivery System, a uniquely smart,...
Overlay Init